Navigation Links
Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Date:9/17/2009

SAN DIEGO, Sept. 18, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported today positive, highly significant top-line results from the BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) trial. BLOSSOM confirms the results previously reported for the BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial and completes the lorcaserin Phase 3 pivotal registration program of 7,190 patients evaluated for up to two years. Arena plans to submit a New Drug Application, or NDA, for lorcaserin to the US Food and Drug Administration, or FDA, in December.

In the one-year BLOSSOM trial, lorcaserin met all primary efficacy and safety endpoints. Patients achieved highly significant categorical and absolute weight loss. Lorcaserin was very well tolerated and was not associated with depression or suicidal ideation. The integrated echocardiographic data set from BLOSSOM and BLOOM rules out a risk of valvulopathy in lorcaserin patients according to criteria requested by the FDA. Treatment with lorcaserin also resulted in significant improvements as compared to placebo in multiple secondary endpoints associated with cardiovascular risk.

"Today there are extremely limited options to meet the needs of physicians and patients in the real world clinical practice of weight management," said Steven R. Smith, M.D., Executive Director of the Florida Hospital Clinical Research Institute. "Physicians need options that have the potential to help the typical obese patient lose significant weight by staying on a safe and well-tolerated treatment. The clinical data show lorcaserin is a solution that could provide physicians with a weight-loss medi
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... ON , Aug. 21, 2014 /CNW/ - Eisai Limited ... the introduction of the first-of-its-kind comic book available in ... tool, has been designed specifically to educate children and their ... Canada affecting more than 300,000 Canadians. Eisai ... health care (hhc) , in which the patient is central ...
(Date:8/21/2014)... 21, 2014 /PRNewswire-iReach/ -- Inc. magazine ... the third straight year, No. 349 in Health ... ranking of the nation,s fastest-growing private companies. The ... most important segment of the economy—America,s independent entrepreneurs. ... Pizza, LinkedIn, Zillow, and many other well-known names ...
(Date:8/21/2014)... 2014  Seventy-one percent of Americans believe the abuse of ... public health and safety issue in the United ... today by Repass & Partners, a Cincinnati ... the severity of the prescription medication abuse problem and the ... serious health situation facing our country," Rex Repass , ...
Breaking Medicine Technology:Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... last two years the Lap Band has skyrocketed to fame ... individuals. As a result, the number of surgeons providing this ... caliber of skill sometimes varying greatly from one surgeon to ... Dr. Michael Feiz has taken the standards of "bedside manner" ...
... JOLLA, Calif., June 21, 2011 Healthcare information technology ... But several pivotal decisions lie ahead with respect to ... critical issues facing healthcare leaders will be examined in ... June 28, 2011 from University of California San Diego ...
Cached Medicine Technology:VIP Care for Lap Band Patients Leads to Life Changing Results 2Health Information Technology: UC San Diego New Seminar Explores Four Critical Issues 2
(Date:8/21/2014)... York, NY (PRWEB) August 21, 2014 ... can often have larger discounts for specific protection plans, ... is now helping consumers to quote life insurance from ... , The local agents that appear inside of ... offer a fast method of price reviews this year. ...
(Date:8/21/2014)... City, Utah (PRWEB) August 21, 2014 ... is pleased to announce the addition of Kerry ... 30 years of healthcare management experience, Gillespie brings ... experience includes multiple executive management positions with prominent ... recently Kerry served as President of Triad Isotopes, ...
(Date:8/21/2014)... 21, 2014 The costs for maintaining pet health ... according to new insurance industry studies. The Quotes Pros company is ... locate affordable plans from all 50 states at http://quotespros.com . ... $50 for a routine visit or complex surgery can use the ... of the system will be asked to provide a zip code ...
(Date:8/21/2014)... NY (PRWEB) August 21, 2014 ... trend among their patients. Alternative medicine is on ... due to millenials. According to The Fiscal Times, ... medical treatments over conventional medicine. , The Fiscal ... how many millenials are embracing alternative medicine. The ...
(Date:8/21/2014)... August 21, 2014 Pulmonary Hypertension ... an Education Forum for PH patients and families ... Pulmonary Hypertension Association – the country’s ... ways to prevent and cure pulmonary hypertension (PH) ... the functioning of the heart and can lead ...
Breaking Medicine News(10 mins):Health News:Life Insurance from Local Agents Now Priced Nationally Through Complimentary Tool Online 2Health News:Kerry Gillespie Appointed as Chief Executive Officer of AVEC Health Solutions 2Health News:Pet Insurance Finder for 50 States Launched at Insurance Website Online 2Health News:Van Uden Center Sees Growth in Alternative Medicine 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3
... (HealthDay News) -- The shingles vaccine is generally safe and ... Shingles, which affects more than 1 million people each year ... by the dormant chickenpox virus, which can reactivate and replicate, ... risk because immunity against the virus that causes shingles declines ...
... By Denise Mann HealthDay Reporter , ... low levels of the heavy metal cadmium may fuel ... them to spread, preliminary research indicates. Found in ... soil and water. Some other main sources of cadmium ...
... WellPoint announced today that Indiana University Melvin and ... to help shape WellPoint,s new health care solutions. ... commercial applications utilizing IBM Watson to help improve ... to make the most informed, personalized treatment decisions ...
... will give you the adult compulsive gambler. That is the ... , a journal published by the Association for Psychological Science. ... toddlerhood, the study found that "people who were rated at ... than other three-year old children were twice as likely to ...
... Clinical Psychological Science ,Association for Psychological Science,s new ... (April 23, 2012) The Association for Psychological Science ... Science , a new peer-reviewed journal focused on publishing ... cutting-edge research across a wide range of conceptual views, ...
... The latest scientific research in children,s health will be ... Academic Societies Annual Meeting. More than 6,500 leaders in ... attend the meeting at the Hynes Convention Center. ... who are conducting original research in children,s health. More ...
Cached Medicine News:Health News:Shingles Vaccine Safe, Underutilized, Study Says 2Health News:Can Heavy Metal in Foods, Cosmetics Spur Breast Cancer Spread? 2Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 2Health News:IU Simon Cancer Center joins WellPoint in developing health care solutions 3Health News:That impulsive, moody preschooler may grow up to be a problem gambler 2Health News:Association for Psychological Science, SAGE launch Clinical Psychological Science 2Health News:Leaders in children's health to gather in Boston 2
... stereomicroscopes are of the single-objective ... mature modular design they optimally ... hand. This is an advantage ... applications will appreciate, not least ...
6.3X Zoom Ratio - Boasting magnifications from 0.8X to 5X, the twin zooming objective optical system developed exclusively by Nikon provides a zoom ratio of 6.3:1. Clickstops at 1X intervals allow ob...
10:1 Zoom Ratio - The parallel optical system of the SMZ-1000 has a 10:1 zoom with clickstops at 1X intervals. It features a zoom range of 0.8X to 8.0X and total magnification (depending on eyepieces...
Fixed Versatility - With a diverse selection of body tubes, stands, lighting techniques and Nikon's world-renowned optics, this modular microscope can be configured to fit nearly any application....
Medicine Products: